ClinicalTrials.gg
CompletedNCT04232163Updated Feb 3, 2023

Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb Recovery After Stroke

An interventional study of Arm Boot Camp in Stroke, Cerebral Infarction and Brain Diseases, sponsored by University of British Columbia. Completed at 7 sites in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2023-02-03.

Primary conditionCerebral InfarctionRegistry: StrokeReclassifiedWhy we changed it
Registry
Stroke — the first condition term the registry derived for this study.
ClinicalTrials.gg
Cerebral Infarction
Why
  1. The study's listed conditions name Cerebral Infarction, a narrower term within Stroke.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

This study will examine the feasibility and effect of a program that combines exercise and feedback from a wearable device on upper limb movement practice and function in individuals with stroke.

Read the detailed description

Participants will be randomized into either the Immediate Treatment Group or the Delayed Treatment group. Both groups will complete the same intervention program. The Immediate treatment group will start the program right away while the Delayed Treatment group will start the program after a 3 week delay. The intervention program is 3 weeks in duration and consists of participants completing at least two hours of exercises (adapted from the Home-GRASP program) daily and wearing an activity monitor on their affected wrist during waking hours for the duration of the intervention. Participants will be asked to meet daily movement count goals based on information from the monitor. Participants will have 6 virtual sessions with a therapist who will teach and monitor exercises thru an online platform (Zoom Video Communications), work with participants to generate and progress daily movement goals and discuss barriers and potential solutions to exercise adherence and/or meeting movement goals.

02

Conditions studied

  • Stroke
  • Cerebral Infarction
  • Brain Diseases
  • Central Nervous System Diseases
  • Cerebrovascular Disorders
  • Brain Ischemia
  • Brain Infarction
  • Vascular Diseases
  • Infarction
  • Nervous System Diseases
  • Cardiovascular Diseases

Keywords

  • Stroke
  • Upper extremity
  • Rehabilitation
  • Wearable device
  • Exercise
  • Randomized Controlled Trial
03

In context

Cerebral Infarction Reclassified

219 studies on the registry are indexed under Cerebral Infarction; 46 are open to participants now.

This study's enrollment of 62 is below the median of 120 across 139 interventional studies indexed under Cerebral Infarction.

Browse Cerebral Infarction studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Compared within Cerebral Infarction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Stroke. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 19 years or older
  • \< 1 year since the stroke occurred
  • Living in the community
  • Have unilateral upper limb impairment
  • Have some ability to move their arm and hand (> 30° shoulder flexion or abduction and Fugl Meyer finger extension score > 0)
  • Are using their affected upper limb in a different way than prior to their stroke (REACH score \< 4)
  • Completed formal physical and occupational therapy rehabilitation for the upper limb
  • Have access to a tablet, computer, laptop or phone with internet and email access.

NOTE: If participant have a caregiver, we would like to invite him/her to assist in this study; however, a caregiver is not a must for participating in this study.

Exclusion criteria

Exclusion Criteria:

  • musculoskeletal/other neurological conditions that limit movement in their arm
  • unable to provide
  • have another medical condition that would affect their ability to participate in the treatment protocol
  • have persistent pain in their affected upper limb that affects their ability to use the limb
  • Unable to speak, understand, or read English (unless another person, [i.e., family member, care taker or friend] can be present and translate during measurement/treatment sessions, and home activities related to the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Immediate Treatment Group

    Participants will receive the intervention right away

    Behavioral: Arm Boot Camp

  • No intervention
    Delayed Treatment Group

    Participants will receive usual care (no intervention), however, they will receive the intervention after a 3 week delay

Interventions

  • BehavioralArm Boot Camp

    The intervention involves a combination of daily homework based upper limb exercises and feedback from an activity monitor to motivate use of the affected upper limb. Participants will be supported through virtual sessions with a therapist.

06

What researchers measure

Primary outcomes

  1. Hand counts captured using an activity monitor

    Participants wear the activity monitor on stroke affected arm during waking hours for 3 consecutive days

    Time frame: Post intervention (immediately following 3 weeks of intervention)

Secondary outcomes

  1. ArmCAM (Arm Capacity and Movement Test)

    The online upper extremity functional assessment consists of 10 items that measure gross movements, supported reach, functional reach and grasp movements, functional wrist movement, and fine motor skills.

    Time frame: Post intervention (immediately following 3 weeks of intervention), follow up (2 months after completion of intervention)

  2. Stroke Impact Scale - hand and strength scales

    Evaluate how stroke has impacted health and life

    Time frame: Post intervention (immediately following 3 weeks of intervention), follow up (2 months after completion of intervention)

  3. Hand count measured during the intervention sessions

    Daily hand count data captured using activity monitor on the stroke affected arm during intervention period

    Time frame: Daily counts within 3 week intervention

  4. REACH Scale

    A self-report measure for individuals with stroke that captures how the affected arm and hand is being used outside of the clinical setting.

    Time frame: Post intervention (immediately following 3 weeks of intervention), follow up (2 months after completion of intervention)

  5. Hand counts captured using an activity monitor

    Participants wear the activity monitor on stroke affected arm during waking hours for 3 consecutive days

    Time frame: Follow up (two months after completion of intervention)

07

Study locations

7 sites
  • University of Calgary
    Calgary, Alberta T2N 2T9, Canada
  • GF Strong Rehab Centre
    Vancouver, British Columbia V5Z 2G9, Canada
  • Riverview Health Centre
    Winnipeg, Manitoba R3L 2P4, Canada
  • Dalhousie University
    Halifax, Nova Scotia B3H 3J5, Canada
  • Parkwood Institute
    London, Ontario B3H 3J5, Canada
  • Toronto Rehabilitation Institute - University Health Network
    Toronto, Ontario Evan.Foster@uhn.ca, Canada
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
08

References and documents

Publications

  • Simpson LA, Mow A, Menon C, Eng JJ. Preliminary Examination of the Ability of a New Wearable Device to Capture Functional Hand Activity After Stroke. Stroke. 2019 Dec;50(12):3643-3646. doi: 10.1161/STROKEAHA.119.026921. Epub 2019 Oct 30. PubMed 31662119 ↗
  • Simpson LA, Barclay R, Bayley MT, Dukelow SP, MacIntosh BJ, MacKay-Lyons M, Menon C, Mortenson WB, Peng TH, Pollock CL, Pooyania S, Teasell R, Yang CL, Yao J, Eng JJ. Virtual Arm Boot Camp (V-ABC): study protocol for a mixed-methods study to increase upper limb recovery after stroke with an intensive program coupled with a grasp count device. Trials. 2022 Feb 8;23(1):129. doi: 10.1186/s13063-022-06047-9. Erratum In: Trials. 2022 Mar 11;23(1):207. doi: 10.1186/s13063-022-06134-x. PubMed 35135585 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04232163
Responsible party
Janice Eng (Principal Investigator, University of British Columbia) — Principal investigator
First posted
Jan 18, 2020
Start date
Aug 15, 2020
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Feb 3, 2023

Study contacts

Janice Eng, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion